{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:29:04Z","timestamp":1790713744161,"version":"4.1.0"},"reference-count":123,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Center for Biomedical Research Excellence","award":["P30GM114736"],"award-info":[{"award-number":["P30GM114736"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Mucolipidosis II and III (ML II\/III) are caused by a deficiency of uridine-diphosphate N-acetylglucosamine: lysosomal-enzyme-N-acetylglucosamine-1-phosphotransferase (GlcNAc-1-phosphotransferase, EC2.7.8.17), which tags lysosomal enzymes with a mannose 6-phosphate (M6P) marker for transport to the lysosome. The process is performed by a sequential two-step process: first, GlcNAc-1-phosphotransferase catalyzes the transfer of GlcNAc-1-phosphate to the selected mannose residues on lysosomal enzymes in the cis-Golgi network. The second step removes GlcNAc from lysosomal enzymes by N-acetylglucosamine-1-phosphodiester \u03b1-N-acetylglucosaminidase (uncovering enzyme) and exposes the mannose 6-phosphate (M6P) residues in the trans-Golgi network, in which the enzymes are targeted to the lysosomes by M6Preceptors. A deficiency of GlcNAc-1-phosphotransferase causes the hypersecretion of lysosomal enzymes out of cells, resulting in a shortage of multiple lysosomal enzymes within lysosomes. Due to a lack of GlcNAc-1-phosphotransferase, the accumulation of cholesterol, phospholipids, glycosaminoglycans (GAGs), and other undegraded substrates occurs in the lysosomes. Clinically, ML II and ML III exhibit quite similar manifestations to mucopolysaccharidoses (MPSs), including specific skeletal deformities known as dysostosis multiplex and gingival hyperplasia. The life expectancy is less than 10 years in the severe type, and there is no definitive treatment for this disease. In this review, we have described the updated diagnosis and therapy on ML II\/III.<\/jats:p>","DOI":"10.3390\/ijms21186812","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T08:29:43Z","timestamp":1600331383000},"page":"6812","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Mucolipidoses Overview: Past, Present, and Future"],"prefix":"10.3390","volume":"21","author":[{"given":"Shaukat A.","family":"Khan","sequence":"first","affiliation":[{"name":"Nemours\/Alfred I. duPont Hospital for Children, Wilmington, DE 19803, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8244-3571","authenticated-orcid":false,"given":"Saori C.","family":"Tomatsu","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, University of Delaware, Newark, DE 19716, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,9,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"ref_2","unstructured":"National Institute of Neurological Disorders and Stroke (2020, July 29). Mucolipidoses Fact Sheet. September 2015, NIH Publication No. 15-4899, Available online: https:\/\/www.ninds.nih.gov\/Disorders\/Patient-Caregiver-Education\/Fact-Sheets\/Mucolipidoses-Fact-Sheet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1126\/science.157.3790.804","article-title":"Mutant enzymatic and cytological phenotypes in cultured human fibroblasts","volume":"157","author":"Leroy","year":"1967","journal-title":"Science"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ajmg.a.32193","article-title":"Molecular order in mucolipidosis II and III nomenclature","volume":"146A","author":"Cathey","year":"2008","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_5","first-page":"113","article-title":"The genetic mucolipidoses. Diagnosis and differential diagnosis","volume":"9","author":"Spranger","year":"1970","journal-title":"Humangenetik"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1093\/ndt\/gfi063","article-title":"Long-term follow-up of metachronous marrow-kidney transplantation in severe type II sialidosis: What does success mean?","volume":"20","author":"Schiff","year":"2005","journal-title":"Nephrol. Dial. Transpl."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.gene.2014.03.053","article-title":"Prenatal skeletal dysplasia phenotype in severe MLII alpha\/beta with novel GNPTAB mutation","volume":"542","author":"Aggarwal","year":"2014","journal-title":"Gene"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.mgene.2014.03.003","article-title":"Pitfalls in the prenatal diagnosis of mucolipidosis II alpha\/beta: A case report","volume":"2","author":"Alegra","year":"2014","journal-title":"Meta Gene"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1055\/s-0038-1636995","article-title":"Challenges in Diagnosing Rare Genetic Causes of Common In Utero Presentations: Report of Two Patients with Mucolipidosis Type II (I-Cell Disease)","volume":"7","author":"Costain","year":"2018","journal-title":"J. Pediatr. Genet."},{"key":"ref_10","first-page":"842","article-title":"The lysosomal storage disorders mucolipidosis type II, type III alpha\/beta, and type III gamma: Update on GNPTAB and GNPTG mutations","volume":"40","author":"Velho","year":"2019","journal-title":"Hum. Mutat."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3345\/kjp.2012.55.11.438","article-title":"A case of mucolipidosis II presenting with prenatal skeletal dysplasia and severe secondary hyperparathyroidism at birth","volume":"55","author":"Heo","year":"2012","journal-title":"Korean J. Pediatr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13023-016-0556-2","article-title":"Clinical, biochemical and molecular characterization of Korean patients with mucolipidosis II\/III and successful prenatal diagnosis","volume":"12","author":"Yang","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000098717","article-title":"Short femurs detected at 25 and 31 weeks of gestation diagnosed as Leroy I-cell disease in the postnatal period: A report of two cases","volume":"22","author":"Yuksel","year":"2007","journal-title":"Fetal Diagn. Ther."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0022-3476(78)81218-9","article-title":"Neonatal presentation of I-cell disease","volume":"93","author":"Sprigz","year":"1978","journal-title":"J. Pediatr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0002-9440(10)64483-5","article-title":"Cathepsin-L, a key molecule in the pathogenesis of drug-induced and I-cell disease-mediated gingival overgrowth: A study with cathepsin-L-deficient mice","volume":"161","author":"Nishimura","year":"2002","journal-title":"Am. J. Pathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1203\/00006450-198104000-00008","article-title":"Cartilage of I-cell disease","volume":"15","author":"Nogami","year":"1981","journal-title":"Pediatr. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.5664\/jcsm.6362","article-title":"Progression of Polysomnographic Abnormalities in Mucolipidosis II (I-Cell Disease)","volume":"12","author":"Wooten","year":"2016","journal-title":"J. Clin. Sleep Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/ajmg.a.61167","article-title":"Sleep-disordered breathing in children with mucolipidosis","volume":"179","author":"Tabone","year":"2019","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.ijporl.2015.02.034","article-title":"Airway management considerations in children with I-cell disease","volume":"79","author":"Mallen","year":"2015","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/jmg.2009.067736","article-title":"Phenotype and genotype in mucolipidoses II and III alpha\/beta: A study of 61 probands","volume":"47","author":"Cathey","year":"2010","journal-title":"J. Med. Genet."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/ajmg.a.35295","article-title":"Mucolipidosis type II alpha\/beta with a homozygous missense mutation in the GNPTAB gene","volume":"158A","author":"Coutinho","year":"2012","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_22","unstructured":"Raas-Rothschild, A., Pohl, S., and Braulke, T. (2012). Multiple enzyme deficiencies: Defects in transport: Mucolipidosis II alpha\/beta; mucolipidosis III alpha\/beta and mucolipidosis III gamma. Lysosomal Storage Dis. A Pract. Guide, 121\u2013126."},{"key":"ref_23","unstructured":"Spranger, J., Brill, P., and Poznanski, A. (2002). Bone Dysplasias. An Atlas of Genetic Disorders of Skeletal Development, Oxford University Press."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/ccr3.835","article-title":"Neonatal mucolipidosis type II alpha\/beta due to compound heterozygosity for a known and novel GNPTAB mutation, and a concomitant heterozygous change in SERPINF1 inherited from the mother","volume":"5","author":"Wood","year":"2017","journal-title":"Clin. Case Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/ejhg.2013.207","article-title":"A novel intermediate mucolipidosis II\/IIIalphabeta caused by GNPTAB mutation in the cytosolic N-terminal domain","volume":"22","author":"Leroy","year":"2014","journal-title":"Eur. J. Hum. Genet. EJHG"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Liu, S., Zhang, W., Shi, H., Yao, F., Wei, M., and Qiu, Z. (2016). Mutation Analysis of 16 Mucolipidosis II and III Alpha\/Beta Chinese Children Revealed Genotype-Phenotype Correlations. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0163204"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s10545-018-0186-z","article-title":"Mucolipidosis type III, a series of adult patients","volume":"41","author":"Oussoren","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/ajmg.a.33170","article-title":"Loss of N-acetylglucosamine-1-phosphotransferase gamma subunit due to intronic mutation in GNPTG causes mucolipidosis type III gamma: Implications for molecular and cellular diagnostics","volume":"152A","author":"Pohl","year":"2010","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1136\/jmg.2003.015222","article-title":"Genomic organisation of the UDP-N-acetylglucosamine-1-phosphotransferase gamma subunit (GNPTAG) and its mutations in mucolipidosis III","volume":"41","author":"Bargal","year":"2004","journal-title":"J. Med. Genet."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.gene.2017.11.052","article-title":"Mucolipidosis type III gamma: Three novel mutation and genotype-phenotype study in eleven patients","volume":"642","author":"Tuysuz","year":"2018","journal-title":"Gene"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/jhg.2016.13","article-title":"Enigmatic in vivo GlcNAc-1-phosphotransferase (GNPTG) transcript correction to wild type in two mucolipidosis III gamma siblings homozygous for nonsense mutations","volume":"61","author":"Velho","year":"2016","journal-title":"J. Hum. Genet."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/0006-291X(81)91177-3","article-title":"Enzymatic phosphorylation of lysosomal enzymes in the presence of UDP-N-acetylglucosamine. Absence of the activity in I-cell fibroblasts","volume":"98","author":"Hasilik","year":"1981","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1016\/S0021-9258(19)69430-5","article-title":"UDP-N-acetylglucosamine:glycoprotein N-acetylglucosamine-1-phosphotransferase. Proposed enzyme for the phosphorylation of the high mannose oligosaccharide units of lysosomal enzymes","volume":"256","author":"Reitman","year":"1981","journal-title":"J. Biol. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"11977","DOI":"10.1016\/S0021-9258(18)43217-6","article-title":"Lysosomal enzyme targeting. N-Acetylglucosaminylphosphotransferase selectively phosphorylates native lysosomal enzymes","volume":"256","author":"Reitman","year":"1981","journal-title":"J. Biol. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1091\/mbc.12.6.1623","article-title":"Lysosomal hydrolase mannose 6-phosphate uncovering enzyme resides in the trans-Golgi network","volume":"12","author":"Rohrer","year":"2001","journal-title":"Mol. Biol. Cell"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1515\/BC.2009.076","article-title":"Glycosylation- and phosphorylation-dependent intracellular transport of lysosomal hydrolases","volume":"390","author":"Pohl","year":"2009","journal-title":"Biol. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0003-9861(83)90511-8","article-title":"Demonstration of the enzymatic mechanisms of alpha-N-acetyl-D-glucosamine-1-phosphodiester N-acetylglucosaminidase (formerly called alpha-N-acetylglucosaminylphosphodiesterase) and lysosomal alpha-N-acetylglucosaminidase","volume":"222","author":"Varki","year":"1983","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"8398","DOI":"10.1016\/S0021-9258(18)43507-7","article-title":"Identification of a rat liver alpha-N-acetylglucosaminyl phosphodiesterase capable of removing \u201dblocking\u201d alpha-N-acetylglucosamine residues from phosphorylated high mannose oligosaccharides of lysosomal enzymes","volume":"255","author":"Varki","year":"1980","journal-title":"J. Biol. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.bbamcr.2008.10.016","article-title":"Sorting of lysosomal proteins","volume":"1793","author":"Braulke","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"31437","DOI":"10.1074\/jbc.271.49.31437","article-title":"Bovine UDP-N-acetylglucosamine:lysosomal-enzyme N-acetylglucosamine-1-phosphotransferase. I. Purification and subunit structure","volume":"271","author":"Bao","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/nm1305","article-title":"Mucolipidosis II is caused by mutations in GNPTA encoding the alpha\/beta GlcNAc-1-phosphotransferase","volume":"11","author":"Tiede","year":"2005","journal-title":"Nat. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1086\/500849","article-title":"Mucolipidosis II (I-cell disease) and mucolipidosis IIIA (classical pseudo-hurler polydystrophy) are caused by mutations in the GlcNAc-phosphotransferase alpha\/beta -subunits precursor gene","volume":"78","author":"Kudo","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"36141","DOI":"10.1074\/jbc.M509008200","article-title":"The alpha- and beta-subunits of the human UDP-N-acetylglucosamine:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase [corrected] are encoded by a single cDNA","volume":"280","author":"Kudo","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.1205677","article-title":"A key enzyme in the biogenesis of lysosomes is a protease that regulates cholesterol metabolism","volume":"333","author":"Marschner","year":"2011","journal-title":"Science"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1172\/JCI5826","article-title":"Molecular basis of variant pseudo-hurler polydystrophy (mucolipidosis IIIC)","volume":"105","author":"Bao","year":"2000","journal-title":"J. Clin. Investig."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2353\/ajpath.2010.090954","article-title":"A novel single-chain antibody fragment for detection of mannose 6-phosphate-containing proteins: Application in mucolipidosis type II patients and mice","volume":"177","author":"Galliciotti","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Pohl, S., Braulke, T., and M\u00fcller-Loennies, S. (2012). A Novel Mannose 6-phosphate Specific Antibody Fragment for Diagnosis of Mucolipidosis type II and III. Anticarbohydrate Antibodies, Springer.","DOI":"10.1007\/978-3-7091-0870-3_13"},{"key":"ref_48","first-page":"34","article-title":"Exome sequencing for mucolipidosis III: Detection of a novel GNPTAB gene mutation in a patient with a very mild phenotype","volume":"2","author":"Alegra","year":"2015","journal-title":"Mol. Genet. Metab. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/ajmg.a.30498","article-title":"A splicing mutation in the alpha\/beta GlcNAc-1-phosphotransferase gene results in an adult onset form of mucolipidosis III associated with sensory neuropathy and cardiomyopathy","volume":"132A","author":"Steet","year":"2005","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/humu.9293","article-title":"A novel mutation in UDP-N-acetylglucosamine-1-phosphotransferase gamma subunit (GNPTAG) in two siblings with mucolipidosis type III alters a used glycosylation site","volume":"24","author":"Tiede","year":"2004","journal-title":"Hum. Mutat."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ajmg.a.30868","article-title":"Missense mutations in N-acetylglucosamine-1-phosphotransferase alpha\/beta subunit gene in a patient with mucolipidosis III and a mild clinical phenotype","volume":"137A","author":"Tiede","year":"2005","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1074\/jbc.M114.612507","article-title":"Analysis of mucolipidosis II\/III GNPTAB missense mutations identifies domains of UDP-GlcNAc:lysosomal enzyme GlcNAc-1-phosphotransferase involved in catalytic function and lysosomal enzyme recognition","volume":"290","author":"Qian","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"10246","DOI":"10.1073\/pnas.1308453110","article-title":"The DMAP interaction domain of UDP-GlcNAc:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase is a substrate recognition module","volume":"110","author":"Qian","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1073\/pnas.1401417111","article-title":"Mislocalization of phosphotransferase as a cause of mucolipidosis III alphabeta","volume":"111","author":"Qian","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1109\/TCBB.2014.2343951","article-title":"A Maximum A Posteriori Probability and Time-Varying Approach for Inferring Gene Regulatory Networks from Time Course Gene Microarray Data","volume":"12","author":"Chan","year":"2015","journal-title":"IEEE\/ACM Trans. Comput. Biol. Bioinform."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/jhg.2009.3","article-title":"Mucolipidosis II and III alpha\/beta: Mutation analysis of 40 Japanese patients showed genotype-phenotype correlation","volume":"54","author":"Otomo","year":"2009","journal-title":"J. Hum. Genet."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1399-0004.2007.00954.x","article-title":"Mucolipidosis II: A single causal mutation in the N-acetylglucosamine-1-phosphotransferase gene (GNPTAB) in a French Canadian founder population","volume":"73","author":"Plante","year":"2008","journal-title":"Clin. Genet."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/humu.20205","article-title":"Identification of mutations in the GNPTA (MGC4170) gene coding for GlcNAc-phosphotransferase alpha\/beta subunits in Korean patients with mucolipidosis type II or type IIIA","volume":"26","author":"Paik","year":"2005","journal-title":"Hum. Mutat."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/ejhg.2015.154","article-title":"Mucolipidosis types II and III and non-syndromic stuttering are associated with different variants in the same genes","volume":"24","author":"Raza","year":"2016","journal-title":"Eur. J. Hum. Genet. EJHG"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJM197111042851923","article-title":"\u201cI-cell\u201d disease: Leakage of lysosomal enzymes into extracellular fluids","volume":"285","author":"Wiesmann","year":"1971","journal-title":"N. Engl. J. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1203\/00006450-197210000-00002","article-title":"I-cell disease: Biochemical studies","volume":"6","author":"Leroy","year":"1972","journal-title":"Pediatr. Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/0003-2697(62)90095-7","article-title":"A modified uronic acid carbazole reaction","volume":"4","author":"Bitter","year":"1962","journal-title":"Anal. Biochem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0021-9258(18)66055-7","article-title":"Method for the determination of hexosamines in tissues","volume":"204","author":"Boas","year":"1953","journal-title":"J. Biol. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1172\/JCI110189","article-title":"Fibroblasts from patients with I-cell disease and pseudo-Hurler polydystrophy are deficient in uridine 5\u2019-diphosphate-N-acetylglucosamine: Glycoprotein N-acetylglucosaminylphosphotransferase activity","volume":"67","author":"Reitman","year":"1981","journal-title":"J. Clin. Investig."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1399-0004.1983.tb02218.x","article-title":"Mucolipidosis II. The clinical, radiological and biochemical features in three cases","volume":"24","author":"Whelan","year":"1983","journal-title":"Clin. Genet."},{"key":"ref_66","first-page":"297","article-title":"Mucolipidosis II or \u201dI-cell diseas\u201d in the newborn infant. 2 new cases","volume":"27","author":"Tames","year":"1987","journal-title":"Esp. Pediatr."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s12098-016-2243-7","article-title":"I Cell Disease (Mucolipidosis II Alpha\/Beta): From Screening to Molecular Diagnosis","volume":"84","author":"Singh","year":"2017","journal-title":"Indian J. Pediatr."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0022-3476(71)80142-7","article-title":"I-cell disease: A clinical picture","volume":"79","author":"Leroy","year":"1971","journal-title":"J. Pediatr."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0009-8981(79)90346-2","article-title":"Glycosaminoglycans from urine and tissues in mucolipidosis II (I-cell disease)","volume":"95","author":"Coppa","year":"1979","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s10545-005-0069-y","article-title":"Heparan sulfate levels in mucopolysaccharidoses and mucolipidoses","volume":"28","author":"Tomatsu","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10545-005-5673-3","article-title":"Keratan sulphate levels in mucopolysaccharidoses and mucolipidoses","volume":"28","author":"Tomatsu","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Langereis, E.J., Wagemans, T., Kulik, W., Lefeber, D.J., van Lenthe, H., Oussoren, E., van der Ploeg, A.T., Ruijter, G.J., Wevers, R.A., and Wijburg, F.A. (2015). A Multiplex Assay for the Diagnosis of Mucopolysaccharidoses and Mucolipidoses. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0138622"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ymgme.2009.10.001","article-title":"Validation of disaccharide compositions derived from dermatan sulfate and heparan sulfate in mucopolysaccharidoses and mucolipidoses II and III by tandem mass spectrometry","volume":"99","author":"Tomatsu","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3390\/metabo4030655","article-title":"Establishment of glycosaminoglycan assays for mucopolysaccharidoses","volume":"4","author":"Tomatsu","year":"2014","journal-title":"Metabolites"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"35283","DOI":"10.1074\/jbc.M111.267930","article-title":"Lysosomal storage causes cellular dysfunction in mucolipidosis II skin fibroblasts","volume":"286","author":"Otomo","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.cca.2006.11.019","article-title":"Cytochemical analysis of storage materials in cultured skin fibroblasts from patients with I-cell disease","volume":"378","author":"Kawashima","year":"2007","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41390-018-0234-2","article-title":"B-cell-specific accumulation of inclusion bodies loaded with HLA class II molecules in patients with mucolipidosis II (I-cell disease)","volume":"86","author":"Yokoi","year":"2019","journal-title":"Pediatr. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"C1387","DOI":"10.1152\/ajpcell.00346.2007","article-title":"Endogenous heparan sulfate and heparin modulate bone morphogenetic protein-4 signaling and activity","volume":"294","author":"Khan","year":"2008","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1182\/blood-2005-02-0657","article-title":"Functional abnormalities of heparan sulfate in mucopolysaccharidosis-I are associated with defective biologic activity of FGF-2 on human multipotent progenitor cells","volume":"106","author":"Pan","year":"2005","journal-title":"Blood"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/emmm.201302979","article-title":"Decreased bone formation and increased osteoclastogenesis cause bone loss in mucolipidosis II","volume":"5","author":"Kollmann","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1600-0854.2011.01203.x","article-title":"Disruption of the Man-6-P targeting pathway in mice impairs osteoclast secretory lysosome biogenesis","volume":"12","author":"Boonen","year":"2011","journal-title":"Traffic"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/0925-4439(91)90069-L","article-title":"Type C Niemann-Pick disease: Spectrum of phenotypic variation in disruption of intracellular LDL-derived cholesterol processing","volume":"1096","author":"Vanier","year":"1991","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10545-014-9794-4","article-title":"Complex lipid trafficking in Niemann-Pick disease type C","volume":"38","author":"Vanier","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1194\/jlr.M500131-JLR200","article-title":"Mannose 6-phosphate receptors, Niemann-Pick C2 protein, and lysosomal cholesterol accumulation","volume":"46","author":"Willenborg","year":"2005","journal-title":"J. Lipid Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"27345","DOI":"10.1016\/S0021-9258(19)74255-0","article-title":"Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, blocks lysosomal cholesterol trafficking in macrophages","volume":"268","author":"Furuchi","year":"1993","journal-title":"J. Biol. Chem."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0005-2760(79)90109-7","article-title":"Acid acylhydrolase deficiency in I-cell disease and pseudo-Hurler polydystrophy","volume":"575","author":"Pittman","year":"1979","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1093\/brain\/aws209","article-title":"Lysosomal dysfunction causes neurodegeneration in mucolipidosis II \u2018knock-in\u2019 mice","volume":"135","author":"Kollmann","year":"2012","journal-title":"Brain"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0022-3476(71)80143-9","article-title":"Clinical, biochemical, and ultrastructural studies in a case of chondrodystrophy presenting the I-cell phenotype in tissue culture","volume":"79","author":"Tondeur","year":"1971","journal-title":"J. Pediatr."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/0006-291X(82)91042-7","article-title":"Is there a mechanism for introducing acid hydrolases into liver lysosomes that is independent of mannose 6-phosphate recognition? Evidence from I-cell disease","volume":"105","author":"Owada","year":"1982","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/0006-291X(82)91076-2","article-title":"Deficiency of UDP-N-acetylglucosamine:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase in organs of I-cell patients","volume":"105","author":"Waheed","year":"1982","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1432-1033.1994.00685.x","article-title":"Mistargeting of lysosomal enzymes in M(r) 46,000 mannose 6-phosphate receptor-deficient mice is compensated by carbohydrate-specific endocytotic receptors","volume":"224","author":"Koster","year":"1994","journal-title":"Eur. J. Biochem."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Idol, R.A., Wozniak, D.F., Fujiwara, H., Yuede, C.M., Ory, D.S., Kornfeld, S., and Vogel, P. (2014). Neurologic abnormalities in mouse models of the lysosomal storage disorders mucolipidosis II and mucolipidosis III gamma. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0109768"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"26709","DOI":"10.1074\/jbc.M114.586156","article-title":"A novel mouse model of a patient mucolipidosis II mutation recapitulates disease pathology","volume":"289","author":"Paton","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1748-5827.1996.tb02444.x","article-title":"Mucolipidosis type II in a domestic shorthair cat","volume":"37","author":"Hubler","year":"1996","journal-title":"J. Small Anim. Pr."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/jhered\/esg080","article-title":"Inheritance, biochemical abnormalities, and clinical features of feline mucolipidosis II: The first animal model of human I-cell disease","volume":"94","author":"Mazrier","year":"2003","journal-title":"J. Hered."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Wang, P., Mazrier, H., Caverly Rae, J., Raj, K., and Giger, U. (2018). A GNPTAB nonsense variant is associated with feline mucolipidosis II (I-cell disease). BMC Vet. Res., 14.","DOI":"10.1186\/s12917-018-1728-1"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.1167\/iovs.07-0452","article-title":"Mice lacking alpha\/beta subunits of GlcNAc-1-phosphotransferase exhibit growth retardation, retinal degeneration, and secretory cell lesions","volume":"48","author":"Gelfman","year":"2007","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1083\/jcb.201407077","article-title":"Mannose 6 phosphorylation of lysosomal enzymes controls B cell functions","volume":"208","author":"Otomo","year":"2015","journal-title":"J. Cell Biol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ymgme.2016.02.001","article-title":"AAV8-mediated expression of N-acetylglucosamine-1-phosphate transferase attenuates bone loss in a mouse model of mucolipidosis II","volume":"117","author":"Ko","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"27198","DOI":"10.1074\/jbc.M704067200","article-title":"Murine UDP-GlcNAc:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase lacking the gamma-subunit retains substantial activity toward acid hydrolases","volume":"282","author":"Lee","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1354\/vp.46-2-313","article-title":"Comparative pathology of murine mucolipidosis types II and IIIC","volume":"46","author":"Vogel","year":"2009","journal-title":"Vet. Pathol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1091\/mbc.e09-05-0398","article-title":"Mice lacking mannose 6-phosphate uncovering enzyme activity have a milder phenotype than mice deficient for N-acetylglucosamine-1-phosphotransferase activity","volume":"20","author":"Boonen","year":"2009","journal-title":"Mol. Biol. Cell"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.2353\/ajpath.2009.090210","article-title":"Altered chondrocyte differentiation and extracellular matrix homeostasis in a zebrafish model for mucolipidosis II","volume":"175","author":"Sias","year":"2009","journal-title":"Am. J. Pathol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1242\/dmm.008219","article-title":"Excessive activity of cathepsin K is associated with cartilage defects in a zebrafish model of mucolipidosis II","volume":"5","author":"Petrey","year":"2012","journal-title":"Dis. Model. Mech."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.bbagen.2016.05.029","article-title":"Enzyme-specific differences in mannose phosphorylation between GlcNAc-1-phosphotransferase alphabeta and gamma subunit deficient zebrafish support cathepsin proteases as early mediators of mucolipidosis pathology","volume":"1860","author":"Matheny","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/jbmr.2722","article-title":"Cathepsin-Mediated Alterations in TGFss-Related Signaling Underlie Disrupted Cartilage and Bone Maturation Associated With Impaired Lysosomal Targeting","volume":"31","author":"Aarnio","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.celrep.2018.02.066","article-title":"TGF-ss Regulates Cathepsin Activation during Normal and Pathogenic Development","volume":"22","author":"Christian","year":"2018","journal-title":"Cell Rep."},{"key":"ref_108","unstructured":"Adam, M.P., Ardinger, H.H., Pagon, R.A., Wallace, S.E., Bean, L.J.H., Stephens, K., and Amemiya, A. (1993). Mucolipidosis III Gamma. GeneReviews((R)), University of Washington."},{"key":"ref_109","first-page":"351","article-title":"Mucolipidoses: Clinical features, biochemistry, diagnosis, genetics, and treatment","volume":"Volume 1","author":"Tomatsu","year":"2018","journal-title":"Mucopolysaccharidoses Update"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.bbmt.2014.06.019","article-title":"Outcomes after hematopoietic stem cell transplantation for children with I-cell disease","volume":"20","author":"Lund","year":"2014","journal-title":"Biol. Blood Marrow Transpl."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/sj.bmt.1704249","article-title":"Continued neurocognitive development and prevention of cardiopulmonary complications after successful BMT for I-cell disease: A long-term follow-up report","volume":"32","author":"Grewal","year":"2003","journal-title":"Bone Marrow Transpl."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Naumchik, B.M., Gupta, A., Flanagan-Steet, H., Steet, R.A., Cathey, S.S., Orchard, P.J., and Lund, T.C. (2020). The Role of Hematopoietic Cell Transplant in the Glycoprotein Diseases. Cells, 9.","DOI":"10.3390\/cells9061411"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16390","article-title":"The effectiveness and cost-effectiveness of enzyme and substrate replacement therapies: A longitudinal cohort study of people with lysosomal storage disorders","volume":"16","author":"Wyatt","year":"2012","journal-title":"Health Technol. Assess."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/0006-291X(72)90310-5","article-title":"A hypothesis for I-cell disease: Defective hydrolases that do not enter lysosomes","volume":"49","author":"Hickman","year":"1972","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/mt.2015.62","article-title":"Pharmacological Chaperone Therapy: Preclinical Development, Clinical Translation, and Prospects for the Treatment of Lysosomal Storage Disorders","volume":"23","author":"Parenti","year":"2015","journal-title":"Mol. Ther."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1016\/S0021-9258(18)45614-1","article-title":"Genistein, a specific inhibitor of tyrosine-specific protein kinases","volume":"262","author":"Akiyama","year":"1987","journal-title":"J. Biol. Chem."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/sj.ejhg.5201623","article-title":"Genistein-mediated inhibition of glycosaminoglycan synthesis as a basis for gene expression-targeted isoflavone therapy for mucopolysaccharidoses","volume":"14","author":"Piotrowska","year":"2006","journal-title":"Eur. J. Hum. Genet. EJHG"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ymgme.2009.06.013","article-title":"Genistein reduces lysosomal storage in peripheral tissues of mucopolysaccharide IIIB mice","volume":"98","author":"Malinowska","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1002\/ajmg.a.34146","article-title":"Improvement in the range of joint motion in seven patients with mucopolysaccharidosis type II during experimental gene expression-targeted isoflavone therapy (GET IT)","volume":"155A","author":"Marucha","year":"2011","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s10545-014-9703-x","article-title":"Genistein increases glycosaminoglycan levels in mucopolysaccharidosis type I cell models","volume":"37","author":"Kingma","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/8904_2015_432","article-title":"Adverse Effects of Genistein in a Mucopolysaccharidosis Type I Mouse Model","volume":"23","author":"Kingma","year":"2015","journal-title":"JIMD Rep."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ymgme.2011.10.015","article-title":"Genistein reduces heparan sulfate accumulation in human mucolipidosis II skin fibroblasts","volume":"105","author":"Otomo","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1089\/hum.2020.034","article-title":"Development of an Antisense Oligonucleotide-Mediated Exon Skipping Therapeutic Strategy for Mucolipidosis II: Validation at RNA Level","volume":"31","author":"Matos","year":"2020","journal-title":"Hum. Gene Ther."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/18\/6812\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:10:45Z","timestamp":1760177445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/18\/6812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,17]]},"references-count":123,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2020,9]]}},"alternative-id":["ijms21186812"],"URL":"https:\/\/doi.org\/10.3390\/ijms21186812","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,17]]}}}